10-Q
XBRL
OXIS INTERNATIONAL QUARTERLY REPORT
- Company
- GT Biopharma, Inc.
- Filed
- January 8, 2015
- Period of Report
- June 30, 2014
- Accession Number
- 0001513160-15-000010
A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →